260 related articles for article (PubMed ID: 20232572)
1. Assessment of the antiobstructive effect of fexofenadine on nasal allergy challenge in patients with seasonal allergic rhinitis.
Mösges R; Lehmacher W; Pasch N; Vent J
Asian Pac J Allergy Immunol; 2009 Dec; 27(4):181-90. PubMed ID: 20232572
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the efficacy and safety of olopatadine and fexofenadine compared with placebo in Japanese cedar pollinosis using an environmental exposure unit.
Enomoto T; Lu HQ; Yin M; Sakoda T; Dake Y; Enomoto K; Ide T; Cheng L
J Investig Allergol Clin Immunol; 2009; 19(4):299-305. PubMed ID: 19639726
[TBL] [Abstract][Full Text] [Related]
3. The effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptoms.
Stokes JR; Romero FA; Allan RJ; Phillips PG; Hackman F; Misfeldt J; Casale TB
J Allergy Clin Immunol; 2012 Feb; 129(2):409-12, 412.e1-2. PubMed ID: 22196768
[TBL] [Abstract][Full Text] [Related]
4. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
Bachert C
Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
[TBL] [Abstract][Full Text] [Related]
5. Effects of fexofenadine on the early response to nasal allergen challenge.
Allocco FT; Votypka V; deTineo M; Naclerio RM; Baroody FM
Ann Allergy Asthma Immunol; 2002 Dec; 89(6):578-84. PubMed ID: 12487223
[TBL] [Abstract][Full Text] [Related]
6. Effects of fexofenadine on inflammatory mediators in nasal lavage fluid in intermittent allergic rhinitis.
Schäper C; Gustavus B; Koch B; Ewert R; Hanf G; Kunkel G; Noga O; Gläser S
J Investig Allergol Clin Immunol; 2009; 19(6):459-64. PubMed ID: 20128420
[TBL] [Abstract][Full Text] [Related]
7. Fluticasone furoate nasal spray is more effective than fexofenadine for nighttime symptoms of seasonal allergy.
Andrews CP; Martin BG; Jacobs RL; Mohar DE; Diaz JD; Amar NJ; Kaiser HB; Vandewalker ML; Bernstein J; Toler WT; Prillaman BA; Dalal AA; Lee LA; Philpot EE
Allergy Asthma Proc; 2009; 30(2):128-38. PubMed ID: 19463203
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine.
LaForce CF; Corren J; Wheeler WJ; Berger WE;
Ann Allergy Asthma Immunol; 2004 Aug; 93(2):154-9. PubMed ID: 15328675
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of terfenadine with fexofenadine on nasal provocation tests with allergen.
Terrien MH; Rahm F; Fellrath JM; Spertini F
J Allergy Clin Immunol; 1999 Jun; 103(6):1025-30. PubMed ID: 10359881
[TBL] [Abstract][Full Text] [Related]
10. Effects of rupatadine vs placebo on allergen-induced symptoms in patients exposed to aeroallergens in the Vienna Challenge Chamber.
Stuebner P; Horak F; Zieglmayer R; Arnáiz E; Leuratti C; Pérez I; Izquierdo I
Ann Allergy Asthma Immunol; 2006 Jan; 96(1):37-44. PubMed ID: 16440531
[TBL] [Abstract][Full Text] [Related]
11. A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis.
Wilson AM; Orr LC; Coutie WJ; Sims EJ; Lipworth BJ
Clin Exp Allergy; 2002 Jan; 32(1):126-32. PubMed ID: 12002729
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies.
Meltzer EO; Scheinmann P; Rosado Pinto JE; Bachert C; Hedlin G; Wahn U; Finn AF; Ruuth E
Pediatr Allergy Immunol; 2004 Jun; 15(3):253-60. PubMed ID: 15209959
[TBL] [Abstract][Full Text] [Related]
13. Mizolastine and fexofenadine modulate cytokine pattern after nasal allergen challenge.
Ciprandi G; Cirillo I; Vizzaccaro A
Eur Ann Allergy Clin Immunol; 2004 Apr; 36(4):146-50. PubMed ID: 15180356
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of desloratadine 5-mg daily and placebo on nasal airflow and seasonal allergic rhinitis symptoms induced by grass pollen exposure.
Horak F; Stübner P; Zieglmeyer R; Harris AG
Allergy; 2003 Jun; 58(6):481-5. PubMed ID: 12757447
[TBL] [Abstract][Full Text] [Related]
15. Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: duration of effect in subjects with seasonal allergic rhinitis.
Day JH; Briscoe MP; Rafeiro E; Hewlett D; Chapman D; Kramer B
Allergy Asthma Proc; 2004; 25(1):59-68. PubMed ID: 15055564
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
Moinuddin R; deTineo M; Maleckar B; Naclerio RM; Baroody FM
Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468
[TBL] [Abstract][Full Text] [Related]
17. Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials.
Compalati E; Baena-Cagnani R; Penagos M; Badellino H; Braido F; Gómez RM; Canonica GW; Baena-Cagnani CE
Int Arch Allergy Immunol; 2011; 156(1):1-15. PubMed ID: 21969990
[TBL] [Abstract][Full Text] [Related]
18. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis.
Howarth PH; Stern MA; Roi L; Reynolds R; Bousquet J
J Allergy Clin Immunol; 1999 Nov; 104(5):927-33. PubMed ID: 10550734
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis.
Van Cauwenberge P; Juniper EF
Clin Exp Allergy; 2000 Jun; 30(6):891-9. PubMed ID: 10848909
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of fexofenadine HCl and pseudoephedrine, alone and in combination, in seasonal allergic rhinitis.
Sussman GL; Mason J; Compton D; Stewart J; Ricard N
J Allergy Clin Immunol; 1999 Jul; 104(1):100-6. PubMed ID: 10400846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
